Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-01

Clinical Trial Update: Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation [NA]

View source ↗

Summary

A clinical trial is evaluating whether curcumin and astaxanthin can lower triglyceride levels and inflammatory markers; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Astaxanthin
  • Curcumin (curcumin)

Snippet

Sponsor: Medinutra LLC | Conditions: Triglycerides | NA | Status: RECRUITING